Condition: Acceptability of Health Care · Sponsor: University of Barcelona
Based on the hypothesis that the strategy of using Closed-Blood Sampling Devices (CSBD, experimental group) compared to the usual practice (waste discard volume, control group), in critically ill adult patients, will decrease the amount of blood withdrawn for laboratory tests, we want to analyze the number of red blood cells (RBC) administered and arterial catheter-related adverse events (catheter-related bacteremia, catheter obstruction, CBSD malfunction, loss of arterial pressure waveform on the patient's bedside monitor) in both study groups, during ICU stay and up to a maximum of 21 days.
This description comes directly from the study's public registry record.
Raurell-Torreda Marta, PhD · 626154955 · mraurell@ub.edu
Always discuss trial participation with your own doctor first.
| Hospital Universitario 12 de Octubre | Madrid, Madrid, Spain | Completed |
| Hospital Rey Juan Carlos | Madrid, Madrid, Spain | Recruiting |
| Hospital Virgen de la Macarena | Seville, Sevilla, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06478160